rslogix 5000 v20 license keyQ:
In-App Script and the Google Scripts Framework
I'd like to use the Google Scripts framework, but I've hit a bit of a wall.
The Scripts Framework is supposed to be used with scripts that reside in an Applications Script Service account, which I am not. What I am doing is using the In-App Script API to run a script that I've written in my personal script service account. Is there some way to tie my scrip into a Scripts Framework instance?
A:
Since version 1.5, the Scripting Framework is agnostic to which account has access to your script. You are free to make your script accessible from any Google account that has the necessary Service Account Credentials.
Have you verified this is the version of the script you're using?
EDIT: Have you tried with the other versions of the Scripting Framework? You need to be using one that is compatible with your version of the Google Apps Scripts API.
A Superficial Spreader Technique for Repair of Full Thickness Defects.
This study describes a new surgical technique for repair of full thickness defects using the novel superficial spreader device. The efficacy of this procedure in providing adequate, stable coverage of a full thickness defect was evaluated. A preliminary study in 3 dogs used the superficial spreader device to facilitate coverage of a full thickness, semi-circular defect in the right hind leg. The spreader was used to press down the edges of the defect and the skin was sutured to the underlying muscle. At the 6-month follow-up the animals were euthanized and the defects were examined by gross dissection and micro-CT to measure healing. A formal study was performed in 24 canines to evaluate the efficacy of the technique in providing stable coverage of full thickness defects. The majority of full thickness defects were created by trimming 20-50% of a skin incision with a rotary cutter. The defects were treated with a superficial spreader device and covered with subcutaneous pockets. Post-surgical healing was monitored by standard clinical and photographic evaluation. Defects were evaluated by gross dissection, micro-CT, and by measuring the distance from the muscle-tendon junction to the implant-tissue interface. The superficial spreader device was used to cover defects created in the right hind legs of 3 dogs and the left hind legs of 21 dogs. All 24 defects were be359ba680
Related links:
Comments